Cargando…
Management Strategies for Older Patients with Low-Risk Early-Stage Breast Cancer: A Physician Survey
When managing older patients with lower-risk hormone-receptor-positive (HR+), HER2 negative (HER2−) early-stage breast cancer (EBC), the harms and benefits of adjuvant therapies should be taken into consideration. A survey was conducted among Canadian oncologists on the definitions of “low risk” and...
Autores principales: | Alzahrani, Mashari, Clemons, Mark, Chang, Lynn, Vendermeer, Lisa, Arnaout, Angel, Larocque, Gail, Cole, Katherine, Hsu, Tina, Saunders, Deanna, Savard, Marie-France |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8774930/ https://www.ncbi.nlm.nih.gov/pubmed/35049675 http://dx.doi.org/10.3390/curroncol29010001 |
Ejemplares similares
-
Experiences and Perceptions of Older Adults with Lower-Risk Hormone Receptor-Positive Breast Cancer about Adjuvant Radiotherapy and Endocrine Therapy: A Patient Survey
por: Savard, Marie-France, et al.
Publicado: (2021) -
Adjuvant bisphosphonate use in patients with early stage breast cancer: a physician survey
por: McGee, Sharon, et al.
Publicado: (2021) -
The COVID-19 pandemic: An opportunity to rethink and harmonise the frequency of follow-up visits for patients with early stage breast cancer
por: Surujballi, Julian, et al.
Publicado: (2021) -
Adjuvant bisphosphonate use in patients with early stage breast cancer: Patient perspectives on treatment acceptability and potential de-escalation
por: McGee, Sharon, et al.
Publicado: (2021) -
The Rethinking Clinical Trials (REaCT) Program. A Canadian-Led Pragmatic Trials Program: Strategies for Integrating Knowledge Users into Trial Design
por: Saunders, Deanna, et al.
Publicado: (2021)